Objective: Compared to open repair of abdominal aortic aneurysms (AAA), endovascular aneurysm repair (EVAR) is associated with decreased perioperative morbidity and mortality. This study sought to examine the outcomes of EVAR in patients >80 years of age. Methods: This was a retrospective review from a prospectively maintained computerized database. A total of 322 patients aged >80 underwent elective EVAR from January 1997 to November 2007. Mean age was 84 years ؎ 3.4 years (range, 80-95 years), and 78.5% were male. Mean aneurysm size was 62 mm ؎ 12 mm (range, 39-110 mm). Results: Mean procedural blood loss was 350 mL (range, 50-2700 mL), and 13.9% required intraoperative transfusion. Mean length of postoperative stay was 2.46 days (median, 1 day; range, 1-42 days), with 54.3% of patients discharged on the first postoperative day. There were 25 (7.8%) perioperative major adverse events. The most common were categorized as device-related (6), cardiac (4), gastrointestinal (4), and bleeding/hematoma (3). The perioperative 30-day mortality rate was 3.1% (10 of 322). Mean follow-up was 25.7 months (range, 1-110 months). Overall, 47 patients (14.6%) required secondary intervention, 7 patients (2.2%) underwent conversion to open repair, and 4 patients (1.2%) died from AAA rupture. Endoleaks occurred in 95 patients (29.4%), with 20 type I, 48 type II, and 27 of indeterminate type; of these, 10 patients with type I endoleaks underwent secondary intervention. Freedom from all-cause mortality at 1 year was 84.3% and at 5 years was 27.4%. Freedom from aneurysm-related mortality at 5 years was 92.9%. Conclusion: EVAR in octogenarians is associated with high procedural success and low perioperative morbidity and mortality. The midterm results of this study support the use of EVAR in this patient population. Further studies are needed to predict short-term and long-term mortality risk, and treatment for other causes of death. ( J Vasc Surg 2010; 51:1354-9.)
Life expectancy in the western world is increasing. In the United States, individuals over 80 years old currently represent the fastest growing demographic of the population and are expected to increase from 3.4 million in 1994 to 9 million by 2030. 1, 2 Therefore, the prevalence of abdominal aortic aneurysms (AAA), an age-related disease, is likely to continue to increase in this population. Currently, elective treatment of AAA is achieved by either open surgical repair or endovascular aneurysm repair (EVAR). Regardless of the chosen technique, patients over 80 years of age experience higher rates of perioperative morbidity and mortality and decreased 5-year survival compared with their younger counterparts. [3] [4] [5] For patients undergoing EVAR, age Ͼ80 was found to be an independent factor for higher mortality and endoleak. 4 AAAs in the elderly population are of particular concern. Many individuals over 80 are excluded from studies on AAA and are not considered for open surgical repair because of their age and comorbidities. 4 Yet, one recent study showed that compared with untreated AAAs, open repair of AAAs in octogenarians was associated with significantly increased life expectancy. 6 The purpose of this study was to report a single institution's experience with elective EVAR in octogenarians and nonagenarians.
METHODS
This study was a retrospective review of a prospectively collected database. Patients were included in the study if they underwent elective EVAR between January 1997 and November 2007 and were 80 years or older at the time of the procedure. The study was approved by the institution's internal review board. All EVAR procedures were performed at the Mount Sinai Hospital, New York, NY. Patients were excluded if they had undergone a previous EVAR at age Ͻ80. Postoperatively, clinical pathways were instituted to streamline hospital management. Primary endpoints consisted of outcomes evaluating technical success, perioperative morbidity and mortality, and long-term outcomes on aneurysm-related mortality. Secondary endpoints included EVAR and stent graft-related complica-tions: presence of endoleak, aneurysm expansion, stent graft migration, AAA rupture, secondary interventions, and conversion to open repair.
The Talent stent graft (Minneapolis, Minn) was the preferred device given its availability in a wide array of graft diameters and length configurations, making it amenable to a large range of patient anatomy. However, a significant proportion of patients were treated outside the instructions for use for the Talent device. The majority of these patients were enrolled before Food & Drug Administration approval and, therefore, no instructions for use was available to guide treatment recommendations.
Preoperative aneurysm size and anatomic characteristics were determined with computed tomography (CT) angiography. Postoperatively, patients were followed at 1, 6, and 12 months, and annually thereafter, with a standardized follow-up protocol that included physical examination, helical CT angiography, and plain abdominal radiographs. No decline in renal function was attributable to the contrast required for CT. Alternative techniques were utilized in patients with renal insufficiency. Endoleaks were detected by CT scan and were reported as primary endoleaks if they occurred within the perioperative period (Ͻ30 days), and otherwise as secondary endoleaks. For the analysis of freedom from endoleak, the event was considered as present from the first time that the endoleak was detected, regardless of whether the endoleak continued, resolved spontaneously, or required intervention. Graft migration was defined by distal displacement of the stent graft of 10 mm or more. Graft breakage and migration were identified by plain abdominal radiographs, and migration was confirmed with CT angiography. Graft patency was also determined with CT angiography in the event of clinical or radiographic evidence of thrombosis.
Technical success was defined as successful intravascular access to the site of the aneurysm, successful deployment of the stent graft with secure fixation and patency, and absence of either type I or III endoleak within the first 24 hours. Clinical success was defined as successful deployment of the device at the desired location without death, type I or III endoleak, graft infection or thrombosis, aneurysm expansion (Ͼ5 mm), aneurysm rupture, or conversion to open repair. 7 Analysis of data was based on the intention-to-treat principle. Patients in whom EVAR failed and who underwent immediate or late conversion to open surgery were always included in the analysis. Results are reported as mean and SD. Rates of freedom from overall death, aneurysmrelated death, secondary procedures, and other EVARassociated late outcomes were estimated with the Kaplan-Meier method. Patients who were lost to follow-up are reflected in the number at risk in the Kaplan-Meier curves. All statistical analyses were conducted using SPSS software (Chicago, Ill). Multivariable analysis was not feasible for this patient population.
RESULTS
A total of 322 patients aged 80 years or older who underwent elective EVAR were included in the study. The mean age was 84 years Ϯ 3.4 years (range, 80-95 years), 78.5% were male, 301 were Ն80 to Ͻ90 years, and there were 21 patients Ն90 years old. The mean follow-up time was 25.7 months (range, 1-110 months). The mean maximum diameter of the aneurysm was 62 mm Ϯ 12 mm (range, 39-110 mm). The majority of patients had four comorbidities, with hypertension and coronary artery disease the two most frequent, affecting 73.6% and 44.4% of patients, respectively (Table I) .
Regional anesthesia (spinal and epidural) was used in the majority of cases (94.8%), with only 1.9% requiring general anesthesia, and the rest (3.2%) were performed under local anesthesia. The average duration of the procedure was 237 minutes Ϯ 95 minutes (80-748 minutes). During the procedure, an average of 289 mL Ϯ 126 mL (80-855 mL) of contrast was used. The mean estimated blood loss was 350 mL Ϯ 316 mL (range, 50-2700 mL), and the blood loss was Ͼ1000 mL in 8 cases. Intraoperative transfusion was required in 45 events (13.9%; Table II ). A bifurcated device was used in 78.2% of the cases, 20.5% of the patients were treated with an aortouni-iliac device, and 1.3% received a tube graft. A total of 69.6% received Talent grafts, whereas the rest received other brands (Table III) . There were no device-specific complications. Mean length of postoperative stay was 2 days Ϯ 4 days (median, 1 day; range, 1-42 days), with 54.3% of patients discharged on the first postoperative day, and 14.2% on the second day after the procedure. One patient remained in the hospital for 42 days. Seven patients required treatment in the intensive care unit (ICU). The technical success rate in the first 24 hours was 95.7%. The 14 technical failures included two instances of primary device failure. In one case, the contralateral limb failed to deploy. In the second, the occluder deployed distal to the desired level and was removed. There were three instances of inability to deploy the device due to difficult anatomy: two procedures were aborted, and one was converted to open repair. Of the remaining nine failures, two were the result of graft migration, three were the result of graft thrombosis (all of which required a femoral-femoral bypass), two were persistent type I endoleaks, and one case of conversion to open repair after vessel injury. Finally, there was one death within the first 24 hours after EVAR in a patient with a history of atrial fibrillation who developed mesenteric thrombosis. Etiology of the mesenteric thrombosis is unknown but is presumed to be related to manipulation of intra-aortic content or embolization related to the patient's baseline atrial fibrillation.
There were 18 cases of intraoperative type I endoleak, 17 of which were proximal. Two cases of proximal endoleak did not resolve despite subsequent cuff extension. One proximal endoleak was fixed with a Palmaz stent (Warren, NJ). There were two cases of acute device migration distally; in the first case, the graft was deployed successfully but descended into the aneurysm sac immediately after a ballooning attempt of the proximal attachment site. The second migration event was fixed intraoperatively with proximal cuff extension. Both cases of migration occurred with Talent grafts -one bifurcated and one aortouni-iliac.
The perioperative mortality rate was 3.1% (10 events) with one death within the first 24 hours, as described above. The cause of death in the remaining nine events included: four cardiac complications, one respiratory failure, one intracranial hemorrhage, one event of sepsis (unrelated to the graft), and two cases of cardiac arrest. There were no perioperative deaths in patients who were converted to open repair.
The clinical success rate at 30 days was 88.2%, with type I endoleaks responsible for the greatest number of clinical failures. There were 25 major adverse events within the 30-day perioperative period. Three patients developed ischemic colitis, two of whom required subsequent subtotal colectomies. All cases of ischemic colitis were due to decreased perfusion of the sigmoid colon. Other significant perioperative events included two cases of myocardial infarction, neither of which was fatal, and two cases of acute renal failure, one of which necessitated temporary hemodialysis. The etiology of the renal failure could not be distinguished in either case, and is presumed to be related to either contrast-induced nephropathy or embolization and ischemia to the renal parenchyma. Overall, 25 patients had one or more complications (Table IV) .
The overall freedom from secondary reintervention (including coil embolization, cuff extension, conversion to open repair, and femoral-femoral bypass) was 92.1% at 1 year and 70.8% at 5 years (Fig 1) . The most common secondary interventions included: cuff extension for type I endoleaks and coil embolization for type II endoleaks (Table V) . Overall, there were two intraoperative, one perioperative, and four late conversions to open repair. Freedom from AAA-related mortality was 95.4% at 1 year and 92.9% at 5 years (Fig 2) . Freedom from all cause mortality at 1 year was 84.3% and at 5 years was 27.4% ( Fig  3) . Overall, there were 16 AAA-related deaths. By definition, this included all 10 perioperative deaths regardless of cause; the other causes of death included two cases of sepsis and four events of AAA rupture. The rate of freedom from endoleak was 73.7% at 1 year, and 54.8% at 5 years (Fig 4) .
Endoleaks occurred in 95 patients (29.4%), with 20 type I, 48 type II, and 27 of indeterminate type (Table VI) . All type 1 endoleaks which were amenable to reintervention (10 patients) were treated. The remainder of patients in whom endovascular management of type I endoleak was 
DISCUSSION
For octogenarians, the decision of how to repair an AAA is often difficult, as this patient population often has numerous major comorbidities that place them at a higher risk when undergoing surgical repair. 8 Age alone may be a predictor of poor outcome with major elective surgery, with one report finding that individuals 80 years old compared with patients 65 to 69 had a twofold higher operative mortality. 9 According to one study, 34.3% of octogenarians undergoing open AAA repair experience at least one major complication, compared to 18.8% for individuals 51 to 60 years old. 10 As a result, many octogenarians are deemed unfit for undergoing open repair. 10 Unfortunately, the 3-year survival for octogenarians turned down for open repair is 17%, with half of all deaths attributable to rupture. 11 When open techniques are used, octogenarians experience increased rates of procedure-related mortality: the mortality for patients in the sixth decade is 2.2% but rises to 7.3% for patients in the eighth decade. 12 In contrast to open repair, EVAR may be performed under regional anesthesia, and is an advisable alternative of treatment for patients considered at high risk for open repair. 13, 14 Compared to previous studies of open repair of AAAs in octogenarians, patients who underwent EVAR in this study had significantly higher rates of nearly all comorbidities. In particular, Haug et al 15 reported rates of hypertension, coronary artery disease, and arrhythmia among octogenarians who underwent open repair to be 36.2%, 29.5%, and 15.2%, respectively, compared to 73.6%, 44.4%, and 26.7% in this study. Aneurysm size was similar between octogenarians who underwent EVAR in this study (6.2 cm) and individuals included in reports on open repair (6.5, 6.7, and 6.8 cm). 5 However, different perioperative outcomes are seen in octogenarians who undergo EVAR compared with those who undergo open repair. Mean procedural blood loss in this study was 350 mL compared to 2800 mL in open repair, and was due nearly entirely to blood loss during introduction of the stent graft to the arteriotomy. 16 Only 1 patient (0.3%) in this study required ventilatory support in the ICU greater than 1 day, compared to 13.3% after open repair. 16 Importantly, perioperative mortality in this study is similar to other recent EVAR studies which range from 1.9% to 5%; however, perioperative mortality in open procedures ranges from 5% to 10%. 4, 5 Each of these findings suggests an advantage for EVAR over open repair in patients Ն80 years of age.
One potential pitfall of EVAR is difficult anatomy, which is largely bypassed with an open surgical approach. As a retrospective study, some selection bias was unavoidable as octogenarians with unsuitable anatomy were unable to undergo EVAR, and thus were necessarily excluded. In a recent report, higher incidence of AAA involving the iliac vessels was reported in octogenarians compared with younger patients. 4 Indeed, in this study, three of the technical failures were directly attributable to complicated anatomy: in 2 cases, the procedures were aborted, and in the third, open conversion was required. There were also 18 acute type I endoleaks that required cuff extension intraoperatively, with 2 cases failing to resolve. Furthermore, there were two instances of intraoperative migration, one of which was ultimately fatal. The high number of type I endoleaks in this study is likely due both to complicated anatomy in this population, and the inclusion of first generation devices that are no longer used. Compared with younger patients, procedure time, contrast load, and requirement for transfusions were higher than cohorts of younger patients who underwent EVAR. 17, 18 This may also be related to complex anatomy in these older patients that would have precluded their inclusion in other trials. Additionally, this series dates back to the initial years of EVAR, and includes a high percentage of aortouni-iliac devices.
For octogenarians, one of the most important factors in recovery is rapid return to baseline and prompt discharge from the hospital. The elderly may have less reserve to tolerate even minor complications. 19 In one recent report, octogenarians who underwent EVAR had a statistically significant more rapid return to baseline despite a lower quality of life at 6 months compared with patients undergoing open repair. 20 However, the importance of rapid recovery to baseline cannot be underestimated, as much of the morbidity associated with open procedures occurs as a result of the prolonged hospital course that these individuals require. In one report, 36% of individuals who underwent open repair of AAA did not return to baseline, and 18% stated that if given the option, they would not have undergone the procedure. 21 Thus, some have argued that even though EVAR is more often associated with secondary interventions compared to open repair, the lower rate of postoperative complications may outweigh the risk of additional procedures. 19 We report a very low rate of major adverse events with EVAR in octogenarians, similar to those in other studies. Additionally, we report a limited rate of secondary procedures.
The disparity between freedom from aneurysm-related mortality and overall mortality at 5 years suggests overwhelmingly that octogenarians who undergo EVAR are protected at least up to 5 years from aneurysm-related death. However, given the life expectancy of this population in light of their age and comorbidities, it is not surprising that the freedom from overall mortality at 5 years is 27.4%. Due to the extensive comorbidities in this patient population, there is no widely accepted patient survival curve for baseline comparison. Therefore, further studies are needed to stratify risk based on comorbidities to better predict which EVAR patients are likely to do well both in the short-term and long-term.
CONCLUSION
Our data show that EVAR in octogenarians is associated with low rates of perioperative morbidity and mortality and low long-term aneurysm-related mortality despite the high rates of comorbidities in these patients. The lower rates of perioperative adverse events and reduced hospital stay may be of significant benefit to this population. We conclude that EVAR is an appropriate option for the treatment of AAA in individuals who have reached 80 years of age. 
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